<div id="readability-page-1">11:47 AM EST, 01/02/2026 (MT Newswires) -- Burcon NutraScience ( BRCNF ) , up more than 10% on last look, said Friday that it has closed the first tranche of its non-brokered private placement of convertible debentures, raising $1.25 million through a direct investment from its manufacturing partner owners.The company will close the private placement in two tranches, for an aggregate principal amount of up to $6.3 million. It expects to close the second and final tranche of the private placement following the special meeting of shareholders on Feb. 20, a statement said.Company insiders and Burcon's manufacturing partner owners are investing a minimum of $5 million in principal amounts. The private placement has been conditionally approved by the Toronto Stock Exchange subject to Burcon complying with the terms of such conditional approval, including receipt of disinterested shareholder approval.Burcon shares are up $0.17, to $1.80, on the Toronto Stock Exchange.Price: 1.80, Change: +0.17, Percent Change: +10.43 MT Newswires does not provide investment advice. Unauthorized reproduction is strictly prohibited.</div>

BRCND

Burcon NutraScience (BRCNF) 的股票在公司完成首批可轉換債券私募配售後上漲超過 10%，籌集了 125 萬美元。此次配售的總目標為 630 萬美元，第二批預計將在 2 月 20 日的股東會議後進行。多倫多證券交易所已有條件批准此次配售，待符合相關條款。Burcon 的股票上漲了 0.17 美元，至 1.80 美元，反映出 10.43% 的變化

Burcon NutraScience 股價上漲 10%，因為完成了債券融資的首筆交易